Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Clinical Genitourinary Cancer|December 12, 2022
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint InhibitorsNeal S Chawla, Nicolas Sayegh, Nishita Tripathi, et al.
Frontiers in Immunology|January 23, 2024
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapyMarice B Alcantara, Wilson S Tang, Dongfang Wang, et al.
Urology Practice|October 30, 2023
Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Pathway InhibitorsGeorges Gebrael, Nicolas Sayegh, Nishita Tripathi, et al.
Cancer Medicine|July 31, 2021
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern CaliforniaNicholas J Salgia, Alexander Chehrazi-Raffle, JoAnn Hsu, et al.
European Urology Focus|April 5, 2024
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based CombinationsGeorges Gebrael, Luis Meza, Xiaochen Li, et al.
Cancers|March 28, 2026
Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based AnalysisSalvador Jaime-Casas, Regina Barragan-Carrillo, Anjaney Kothari, et al.
JAMA Network Open|June 9, 2025
Clinical Outcomes in Patients With Muscle-Invasive Urothelial Carcinoma Treated With NivolumabRegina Barragán-Carrillo, Hedyeh Ebrahimi, William S John, et al.
JCO Precision Oncology|April 7, 2023
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell CarcinomaAlexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 21, 2010
[Clinicopathologic analysis of papillary renal cell carcinoma]Wei Zhang, Yu-jun Li
JCO Oncology Practice|July 30, 2026
Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United StatesGeorge Zhang, Jadon Fann, Daniela V Castro, et al.
Pageof 10